Harmful Effects of Drugs on the Body & Gateway Drug Theory

Gateway Drugs, Addiction & the Body–Mind Interface

Gateway-drug theory proposes a sequential pathway: early experimentation with comparatively “mild” psycho-actives (e.g., nicotine or alcohol) statistically precedes, and increases the probability of, later consumption of “hard” substances such as cocaine, heroin, or methamphetamine. Although the causal chain is debated in scientific literature, epidemiological patterns consistently show that use of legally accessible products often constitutes the first rung on the ladder toward polysubstance abuse.

Addiction itself is now classified as a chronic, relapsing brain disease. Neuro-imaging studies reveal that repeated drug exposure remodels the mesolimbic reward circuit—principally the ventral tegmental area, nucleus accumbens, and pre-frontal cortex—altering dopamine signalling, impulse control, and stress-response pathways. These neuroadaptations explain why the condition is marked not merely by physical dependence, but also by compulsive craving and loss of self-regulation.

Tobacco & Cigarettes

Cigarettes are paper-wrapped cylinders filled with dried, shredded tobacco. Ignition produces an aerosol containing nicotine (the primary psycho-active alkaloid), plus roughly 7{,}000 identified chemicals—of which 69 are established carcinogens (e.g., benzene, formaldehyde, and polycyclic aromatic hydrocarbons). Nicotine’s rapid blood-brain penetration (≈10 s via pulmonary capillaries) leads to acute dopamine release, making it highly reinforcing.

Why People Smoke

Peer modelling, targeted advertising, parental smoking, self-medication for stress or weight control, and the adolescent drive for novelty collectively fuel initiation. Daily data snapshots:

  • 4{,}000 minors (<18) try their first cigarette every day.

  • ≈1.5 \times 10^{6} cigarette packs are bought for minors each day.

  • Chronic users lose 13\text{–}14 life-years on average; about 30\% of teen smokers progress to lifelong use and premature, smoking-related mortality.

Short-Term Somatic & Aesthetic Consequences

– Halitosis, oral dysgeusia, smoky odour, yellow teeth, muscle catabolism, hyper-acidity, asthma flare-ups, persistent cough, dull & dehydrated skin, and immediate nicotine dependence.

Long-Term Pathology Profile

Cardio-vascular (hypertension, myocardial infarction, stroke), oncologic (lung, oropharyngeal, pancreatic), pulmonary (emphysema, chronic bronchitis), reproductive (erectile dysfunction, sperm abnormalities, menstrual irregularities), and teratogenic (miscarriage, prematurity, low birth-weight) endpoints dominate the risk spectrum.

Passive & Residual Smoke

  1. Primary smoke: drawn directly into smoker’s lungs.

  2. Secondary smoke (Environmental Tobacco Smoke, ETS): mixture of sidestream (burning tip) + exhaled mainstream; unfiltered, therefore more toxic to bystanders.

  3. Tertiary or third-hand smoke: microscopic residue of ETS that clings to fabrics, walls, and dust—continually off-gassing carcinogens long after the cigarette is extinguished.

Ethically, public smoking imperils non-smokers (infants are particularly vulnerable) and degrades communal air quality. Ecologically, cigarette butts constitute the #1 item in global urban litter; they leach nicotine into waterways, killing aquatic fauna, and are implicated in accidental fires.

Alcohol (Ethyl Alcohol)

Alcoholic beverages arise from fermentation or distillation of plant sugars into ethanol—a central-nervous-system depressant that slows motor coordination, reaction time, and cognitive processing. The beverage class (beer, wine, spirits) is defined by the source substrate and %ABV (alcohol by volume).

Non-Beverage Alcohols

• Methanol – solvent; 100 mL can cause optic-nerve destruction or death.
• Isopropyl alcohol – disinfectant; inhalation/ingestion produces CNS depression + metabolic acidosis.
• Denatured alcohol – ethanol rendered non-potable by methanol and additives; industrial fuel/solvent.

Motivators & Deterrents

Reasons to drink include social facilitation, anxiety relief, curiosity, modelling, psycho-active euphoria, or weighty peer norms. Reasons to abstain encompass religious doctrine, fear of dependence, pregnancy, concomitant medication, chronic illness, or alcohol intolerance.

Acute Intoxication Manifestations

Slurred speech, blurred vision, impaired judgement, ataxia, decreased pain perception, vomiting, diarrhoea, respiratory depression, risky disinhibition, blackouts, and disorientation.

Chronic Sequelae

Neurological (cortical atrophy, Wernicke–Korsakoff), cardiac (dilated cardiomyopathy, arrhythmias, hypertension), hepatic (fatty liver → hepatitis → fibrosis → cirrhosis), pancreatitis, immuno-suppression, and elevated carcinogenic risk (oral, oesophageal, hepatic, breast).

Depressants (Pharmacological Class)

Depressants attenuate CNS excitability by potentiating \gamma-aminobutyric acid (GABA) or mimicking endogenous opioids.

• Barbiturates – historically for anxiety, insomnia, seizures; narrow therapeutic index.
• Opioids – natural or synthetic agonists at \mu-opioid receptors; primary analgesics but liable to profound dependence.
• Alcohol – discussed above.

Physiological Impact

Short-term: slowed heart/respiratory rate, hypotension, vertigo, sedation, poor focus. Long-term: depressive mood disorder, sexual dysfunction, sleep architecture disruption, glucose dysregulation, and severe withdrawal syndromes (delirium tremens, seizures).

Stimulants

Stimulants enhance synaptic monoamines (dopamine, norepinephrine) producing heightened alertness.

• Methamphetamine – structurally similar to amphetamine but crosses BBB rapidly; potent dopamine releaser.
• Nicotine – stimulant component of tobacco.
• Cocaine – blocks monoamine re-uptake; forms: powder (snorted), crack (smoked).

Short-Term Effects

Hyper-vigilance, euphoria, anger, paranoia, anorexia, sensory amplification, headaches, seizures.

Long-Term Effects

Cardio-vascular catastrophe (MI, stroke), mood disorders, sexual dysfunction, pulmonary fibrosis (from smoking), transmissible infections (HIV, hepatitis via shared needles), nasal septum necrosis (snorting), intestinal ischemia (oral ingestion).

Narcotics (Medical Opioids)

Definition: analgesic compounds with high abuse potential; legitimate use strictly under prescription.

Examples: opium, heroin (diacetyl-morphine), morphine, codeine, methadone.

Core Effects

Profound analgesia, euphoria, respiratory depression, GI hypo-motility (constipation), tolerance escalation, and withdrawal syndrome characterised by mydriasis, pilo-erection, diarrhoea, and bone pain.

Hallucinogens

Drugs altering perception, mood, and thought, often via serotonergic (5-HT2A) pathways.

Classic Hallucinogen – LSD

Synthesised from lysergic acid (ergot fungus on rye). Potent at micro-gram doses; ingested via blotter tabs. Produces synaesthesia, ego-dissolution, “trip” experiences lasting 8\text{–}12 h.

Dissociative – PCP

Originally an anaesthetic; now illicit. Powder, liquid, pill forms. Induces detachment, numbness, and potentially violent psychosis.

Physiological & Psychological Spectrum

Short-term: tachycardia, hypertension, xerostomia, insomnia, derealisation. Long-term: persistent hallucinations, flashbacks, cognitive deficits, weight loss, depression, suicidality, seizures, and respiratory compromise.

Integrated Ethical, Social & Environmental Considerations

• Substance abuse burdens public health systems and widens socio-economic disparities.
• Second-hand exposure violates the right to a healthy environment, creating civic duties for smokers to minimise harm.
• Marketing strategies exploit adolescent neurodevelopmental vulnerability; hence regulatory frameworks (sin taxes, age restrictions, graphic warnings) are justified by utilitarian ethics.
• Environmental externalities—from cigarette litter to chemical solvent runoff—link personal substance choices with planetary stewardship.

Formulae & Quantitative Summaries

\begin{aligned}
\text{Daily teen initiates} &= 4{,}000\[4pt]
\text{Packs acquired for minors/day} &\approx 1.5\times10^{6}\[4pt]
\text{Life-years lost (mean)} &= 13!\text{–}14\[4pt]
\text{Identified cigarette chemicals} &= 7{,}000\[4pt]
\text{Confirmed carcinogens} &= 69
\end{aligned}

References & Further Reading

(Selected foundational sources from the transcript—full bibliographic details in original slide deck.) DrugWise (Barbiturates); Johns Hopkins Medicine (Opioids); Gateway Foundation (Effects of Drug Abuse); Alcohol & Drug Foundation (Depressants); NIDA (Hallucinogens); Philippine DEA Annual Report, etc.